Ajinomoto Bio-Pharma Services
More Content From Ajinomoto Bio-Pharma Services
-
Working with Lipid Nanoparticle Based Drugs (LNPs) and Other Complex Formulations
If you are considering an LNP-based formulation or another complex drug, here are several points to consider to make the process more efficient.Infographics Released on 02.29.2024
-
How To Select The Ideal HPAPI Manufacturing Partner
To ensure safety during HPAPI production, manufacturers must have the knowledge to effectively use containment and design high-quality equipment.White Papers / Tech Papers Released on 02.29.2024
-
To GMP Or Not To GMP? That Is The (Plasmid) Question
How can you maintain a manageable budget while procuring a high-quality plasmid supply?White Papers / Tech Papers Released on 02.29.2024
-
Leveraging CDMO's in Pharma's Drive Towards Net Zero
The push to reduce carbon emissions across some of the most energy-intensive industries has created new complexities for many companies.Sponsored Content Released on 04.19.2023
-
Aji Bio-Pharma “About Us” Video
Watch the animated capabilities video to learn more about Aji Bio-Pharma.Videos Released on 04.18.2023
-
Mark Cassidy, President & CEO, Aji Bio-Pharma Europe
Mission and VisionVideos Released on 04.18.2023
-
Identifying Sustainable Pathways Toward Oligonucleotide Therapeutics
After nearly 50 years of research and development, oligonucleotide therapeutics are starting to make their mark on the pharmaceutical scene.White Papers / Tech Papers Released on 03.14.2023
-
MAY THE FLOW BE WITH YOU: CONTINUOUS FLOW MANUFACTURING OF PHARMACEUTICAL INGREDIENTS
A clear increase in continuous flow processes has emerged over the past decade.White Papers / Tech Papers Released on 12.19.2019
-
5 ADC Manufacturing Challenges You Need To Know
Below are five key areas where pharmaceutical manufacturers may face the biggest uphill battles.White Papers / Tech Papers Released on 08.27.2019
-
Simplifying Recombinant Protein Production: Breaking Down the Corynex Protein Expression System
The rise of biologics is having a dramatic impact on how physicians treat many serious and chronic illnesses.White Papers / Tech Papers Released on 08.27.2019
-
Critical Factors of Fill Finish Manufacturing For Biologics
The bulk drug substance, formulation, and sterile filtering and filling of the final drug product all require special handling procedures.White Papers / Tech Papers Released on 08.27.2019
-
Is Your Complex Formulation Process Set Up for Success?
Often, the implementation of specialized equipment and/or processes is necessary to ensure successful formulation.White Papers / Tech Papers Released on 08.27.2019
-
Preparing for Your CDMO Selection Process
Finding the CDMO that is right for your company and project can be a daunting task, particularly if this is your first time outsourcing.White Papers / Tech Papers Released on 08.27.2019
-
Biologics candidate enters clinical trials for first time using CORYNEX® Protein Expression System
...News Releases Released on 10.04.2016
Related Content
-
-
Breaking News | Promotions & Moves
Exothera Names Darren Leva as Chief Business Officer
Leva brings 20 years of broad commercial expertise to Exothera from a range of experiences with CDMOs, therapeutics, and software companies.02.01.23
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Lonza Further Invests in Drug Product Manufacturing Capabilities
New filling line to process various modalities, including monoclonal antibodies, bioconjugates, viral vectors, and other gene therapy products.09.22.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate
Will initiate the GMP manufacturing of the clinical batches of FluGen’s M2SR influenza vaccine candidate for upcoming clinical trials.09.21.21
-
Breaking News | Promotions & Moves
Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer
Schetter has a proven track record across the entire biopharmaceutical value chain.09.20.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
AGC Biologics Expands pDNA and mRNA Manufacturing Capacity
Expansion at Heidelberg site allows the CDMO to meet increasing demands of the cell and gene therapy market.09.14.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
GeneQuine, Exothera Enter Gene Therapy Partnership
To support the next stage of osteoarthritis gene therapy development program.09.10.21
-
Breaking News | Collaborations & Alliances | Drug Development
GeneQuine Contracts Exothera to Support the Development of Its Osteoarthritis Gene Therapy
GQ-303, the gene therapy candidate, turns joint cells into factories for production of the therapeutic protein proteoglycan 4.09.10.21
-
APIs | Drug Development
API Development Trends
Why is it important to consider solid form in API development?John Mykytiuk, Jamie Marshall and Andrew Blythe-Dickens, Sterling Pharma Solutions 09.09.21
-
A Strong Partnership in Drug Development
How CDMOs and consultants mutually benefit their clients.09.09.21
-
Drug Development
Partnering with a CDMO for Orphan Drug Development
Challenges and considerations for advancing rare disease drugs to market.Susan Billings, Vice President & Global Head of Business Development, Curia (formerly known as AMRI) 09.09.21
-
Choosing and Managing a CDMO
Speed up your time-to-market, keep development costs under control and smooth the FDA approval and commercial launch process.Dana Toops, President, Avema Pharma Solutions 09.09.21
-
Breaking News | Industry News | Promotions & Moves
Forge Biologics Expands Leadership Team
Announces two key hires in process development and medical affairs.08.30.21
-
Bio News | Breaking News | Facilities | Industry News
Umoja Biopharma Breaks Ground on Cancer Drug Manufacturing Facility
State-of-the-art 146,000 square foot facility in Louisville, CO will produce next-generation CAR T immunotherapies.08.30.21
-
Breaking News | Industry News | Promotions & Moves
PharmaBlock Appoints Dr. Xudong Wei as SVP and Head of CDMO Business
Wei’s scientific and management career spans over 20 years.08.30.21
-
Bio News | Breaking News | Industry News
PBS Biotech Scales-Up Manufacturing Solutions for Cell Therapies
Raises $10 million to grow its product offerings and capabilities.08.20.21
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Beroni Begins Manufacture of Anti-Cancer Drug PENAO
Inks contract manufacturing deal with Aurigene Pharma Services.08.19.21
-
Analytical Services | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Innoforce Expands Cell and Gene Therapy Capabilities
Opens analytical development and process development facility in Hangzhou, China.08.17.21
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Cellectar, Evergreen Enter Clinical Manufacturing and Supply Agreement
Evergreen to provide clinical and commercial supply of iopofosine I-131.08.17.21
-
Breaking News | Drug Delivery | Industry News
Aptar Pharma, Pharmaxis Enter Orbital DPI Agreement
Aptar has the option to acquire rights to Pharmaxis’ Orbital high payload dry powder inhaler.08.17.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Lykan and Vineti Form Cell Therapy Agreement
Partnership will streamline process development and manufacturing to deliver therapies to patients in need.08.13.21
-
Biologics, Proteins, Vaccines | Breaking News | Promotions & Moves
Discovery Life Sciences Appoints Cell & Gene Therapy CTO
Dr. Clarke will work to further establish the company as a global leader in cell and gene therapy materials and analytical services.08.12.21
-
Breaking News | Drug Development
Precision NanoSystems Announces Plans to Expand Global Headquarters
Will improve capabilities to include the clinical manufacturing of RNA vaccines and therapeutics.08.11.21
-
Biologics, Proteins, Vaccines | Breaking News
Evotec Opens cGMP Manufacturing Facility in Redmond, WA
Expands capabilities into commercial biologics manufacturing and adds late stage clinical development and commercial supply for drug substance.08.11.21
-
Breaking News | Facilities | Industry News
Regeneron Investing $1.8B in Tarrytown, NY Campus
New York's largest biotech company creating an additional 1,000 jobs over five years.07.29.21
-
Bio News | Biosimilars | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Abzena, BioXpress Therapeutics Enter Biosimilar Tie-up
Partnership to support the development and manufacture of biosimilars for global customers.07.29.21
-
Breaking News | Facilities | Industry News
Archimica Completes Expansion of Its Multi-Purpose Manufacturing Capacity
Recent investment adds significantly to the company's capabilities.07.27.21
-
Breaking News | Facilities
Capsida Biotherapeutics Opens Facility in Thousand Oaks
New 15,000 square-foot facility will enable industry leading end-to-end gene therapy manufacturing capability.07.23.21
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Marvel Biotechnology Begins cGMP Manufacturing of Lead Candidate
Enters manufacturing agreement with Ausun Pharma for lead asset MB-204.07.22.21
-
Breaking News | Promotions & Moves
TCR2 Therapeutics Appoints Chief Technical Officer
Peter Olagunju to oversee process development, manufacturing, quality control and technical operations for the company’s TRuC-T cell programs.07.21.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News
GentiBio, Forge Biologics Ink Development and Manufacturing Agreement
Partnership to support GentiBio’s cell therapy pipeline with AAV process development, scale up and GMP manufacturing services.07.16.21
-
Breaking News | Industry News | Promotions & Moves
Daicel Chiral Technologies Opens New Facility in Ann Arbor, MI
Also hires new HPLC chemist and promotes sales representative.07.14.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Curia to Acquire US-based LakePharma
Expanding end-to-end R&D capabilities and scale for biologics.07.14.21
-
Breaking News | cGMP Manufacture
Thermo Fisher Scientific Expands Gene Therapy Portfolio
Adds new set of solutions to support more efficient adeno-associated viral manufacturing.07.07.21
-
VectorBuilder, Univercells Form Viral Vector Production Pact
Aims to develop a portfolio of optimized viral vector manufacturing protocols.07.06.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Cytotoxics and High Potency Manufacturing | Industry News
Novasep, Exelixis Ink ADC Manufacturing Agreement
Covers the cGMP clinical manufacturing of a next-generation ADC drug candidate.07.06.21
-
Analytical Services | Breaking News | cGMP Manufacture | Collaborations & Alliances | Formulation Development
Selexis, KBI Biopharma, Immatics Partner to Advance TCR Program
Will leverage integrated services from Selexis and KBI as part of Immatics’ development of TCR Bispecifics, designed to detect, target and attack tumor cells.06.30.21
-
eTheRNA, Quantoom Collaborate to Develop Novel RNA Production System
Aims to develop an RNA production system for both research and GMP-grade material.06.29.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Genezen Breaks Ground on cGMP Lentiviral Vector Production Facility
First phase will see the construction of a 25,000 square feet site including a process development lab expansion.06.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Process Development
Catalent to Acquire RheinCell Therapeutics
Strengthens path towards industrialization of induced pluripotent stem cell-based therapies.06.25.21
-
Breaking News | Collaborations & Alliances
CellPoint and Lonza Enter CAR-T Cell Collaboration
Will work together to deliver CAR-T Cell therapies to patients at point-of-care.06.24.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Frontera Therapeutics Starts GMP Manufacturing Facility Construction
Designed for clinical manufacturing and initial commercial manufacturing of rAAV gene therapy products.06.23.21
-
Breaking News | Clinical Trial Materials | Industry News
CaroGen, BioCentriq Enter Clinical Manufacturing Pact
BioCentriq to provide clinical manufacturing to support Phase 1 clinical trials of CaroGen's lead immunotherapy candidate, CARG-201.06.22.21
-
Breaking News | Collaborations & Alliances | Industry News
KBI Biopharma, AM-Pharma Enter Manufacturing Agreement
Partnership supports future commercial manufacturing for AM-Pharma’s potential kidney disease treatment.06.17.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
Dendreon Pharmaceuticals Establishes Contract Manufacturing Division
Now offers end-to-end manufacturing of complex cell therapies and patient logistics for partner programs.06.15.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Injectables
BD Hits 2 Billion Injection Device Milestone for COVID-19 Vaccinations
Company now supplying more than 40 countries for pandemic vaccination campaigns.06.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
Vibalogics Expands Manufacturing Capacity
Invests an additional $50 million to further expand cGMP manufacturing capacity for viral vectors.06.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Process Development
Portonbio Enters CAR-T Partnership with KAEDI
CDMO will provide KAEDI with CMC services for multiple projects.Tim Wright, Editor, Contract Pharma 06.07.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
VIVEbiotech Launches Lentiviral Vectors Mfg. Plant
Increases production capacity by 400% to deliver commercial-size batches for Cell and Gene Therapy Sector.Kristin Brooks 06.04.21
-
Breaking News | Industry News
Biovectra Inc. Unveils New Logo and Brand
New image reflects the growing company’s full suite of expertise and core values.Charles Sternberg, Assistant Editor 06.03.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Samsung Biologics Signs Agreement with Kahr Medical
Will support Kahr’s drug candidate DSP502, a TIGITxPD1 fusion protein.Charles Sternberg, Assistant Editor 06.03.21
-
Breaking News | Drug Delivery | Facilities | Industry News | Solid Dosage/Creams/Ointments
MedPharm Opens New Manufacturing Facility
State-of-the-art facility in Durham, NC expands the CDMO’s topical and transdermal delivery capabilities.Tim Wright, Editor, Contract Pharma 06.01.21
-
Breaking News | Collaborations & Alliances | Industry News
Hovione and iBET Form Strategic Collaboration
Will combine knowledge from both partners to create innovation in new therapeutic fields.Tim Wright, Editor, Contract Pharma 05.27.21
-
Breaking News | Collaborations & Alliances | Industry News
Univercells Technologies Collaborates with NIBRT
Adds scale-X carbo integrated system at Dublin facility for intensified upstream viral manufacturing demonstrations and training.Charles Sternberg, Assistant Editor 05.19.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
WuXi Biologics, WuXi STA Establish WuXi XDC JV
To provide contract development and manufacturing of bioconjugates including antibody-drug conjugates (ADCs).Kristin Brooks 05.14.21
-
Breaking News | Facilities | Industry News
CordenPharma Colorado Continues Expansion
Unveils plan to double its largest peptide purification suite.Tim Wright, Editor, Contract Pharma 05.13.21
-
Bio News | Breaking News | Facilities
NJ Bio Moves Headquarters to Princeton, New Jersey
The 35,000-square-foot site was formerly occupied by Bristol Myers Squibb.Tim Wright, Editor, Contract Pharma 05.11.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
3P and Buzzard Pharmaceuticals Enter Cancer Collaboration
Enter into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra.Charles Sternberg, Assistant Editor 05.07.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Catalent Acquires Commercial-Scale Plasmid DNA Mfg. Facility
Promethera’s Hepatic Cell Therapy Support SA include's 32,400 sq.-ft. facility in Gosselies, Belgium.Kristin Brooks, Contract Pharma 05.06.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
BioVaxys Inks Deal with CDMO BioElpida
Includes clinical-grade bioproduction and aseptic packaging for ovarian cancer vaccine candidate BXV-0918A.Tim Wright, Editor, Contract Pharma 05.05.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Clean Biologics Acquires Biodextris
To establish North American presence and expand activities with Biodextris’ complementary services.Tim Wright, Editor, Contract Pharma 05.05.21
-
Analytical Services | Bioanalytical Services | Breaking News | cGMP Manufacture | Drug Development | Industry News | R&D
AMRI Adds R&D and Mfg. Solutions for Orphan Products
Targeted investments globally expand scale and compound handling capabilities at facilities in Albany, Grafton, and Glasgow.Kristin Brooks 04.30.21
-
Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
Asher Bio, ProBioGen Ink Development, Mfg. Agreement
ProBioGen to provide cell line development, process development and GMP manufacturing at 1000 L bioreactor scale of Asher's lead immuno-oncology candidate.Kristin Brooks 04.26.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
RDIF, Minapharm to Make Over 40M Doses of the Sputnik V Vaccine in Egypt
Production will take place in Minapharm’s biotech facility in Cairo for global distribution.Tim Wright, Editor, Contract Pharma 04.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Resilience Acquires Ology Bioservices
Continues expansion with acquisition of biologics manufacturing company.Tim Wright, Editor, Contract Pharma 04.19.21
-
Breaking News | Promotions & Moves
AGC Biologics Appoints Jun Takami GM of Chiba Site
Mr. Takami brings more than 15 years of experience in the pharmaceutical industry.Kristin Brooks 04.08.21
-
Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development | Industry News
Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
Work together to develop and commercialize CHI’s novel dry-powder inhaler product.Charles Sternberg, Assistant Editor 04.07.21
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News
AstraZeneca, Aji Bio-Pharma Expand Mfg. Agreement
Expands scope of Aji Bio-Pharma's service offerings to include aseptic fill finish services at its San Diego, CA facility.Kristin Brooks 03.30.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Ajinomoto, Bright Peak Enter Immunocytokines Research Pact
Exclusive license agreement to incorporate Ajinomoto Co.’s AJICAP site-specific bioconjugation technology for the development of Bright Peak Immunocytokines.Kristin Brooks 03.30.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
CyanVac and Exothera Enter COVID-19 Vaccine Partnership
CDMO Exothera selected for the development and GMP manufacturing of intranasal vaccine candidate for Phase III clinical trial is Europe and the U.S.Tim Wright, Editor, Contract Pharma 03.25.21
-
Breaking News | Facilities | Industry News
Raybow Pharmaceutical Expands in U.S.
China-based CDMO will invest $15.8 million in North Carolina facility.Tim Wright, Editor, Contract Pharma 03.23.21
-
Breaking News | Drug Development | Facilities | Industry News | Parenterals
Eisai Begins Construction of New Injection/Research Building
To accommodate expanded drug discovery targets and new modalities such as antibodies, ADCs, and nucleic acid drugs.Kristin Brooks 03.22.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Lyophilization | Process Development
WuXi Biologics to Acquire CMAB Biopharma Group
Will increase 7000L drug substance capacity (MFG21) and drug product capacity (DP11) for liquid and lyophilization within its global manufacturing network.Kristin Brooks 03.18.21
-
Breaking News | Clinical Trial Materials | Cold Chain Management | Industry News
PCI Pharma Services Expands Cold Chain Clinical Supply Storage
Adds significant capacity and several new cold chain storage conditions, which now include temperatures from controlled room temperature to -80°C.Kristin Brooks 03.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
High Purity New England & Univercells Technologies Unveil Bioprocessing Solutions
New highly scalable line of bioreactors designed to ensure seamless scalability from early process development to commercial manufacturing.Tim Wright, Editor, Contract Pharma 03.09.21
-
cGMP Manufacture | Process Development | Scale-up/Technology Transfer
Process Intensification: Understanding the Optimal Way to Maximize Productivity
Overcoming challenges of implementation and achieving increased volume, reduced timelines, decreased footprint, lower cost of goods, and increased flexibility.Priyanka Gupta, Head of Market Entry Strategy for Protein Based Therapeutics, Sartorius 03.09.21
-
Bio News | Biologics, Proteins, Vaccines | Facilities | Industry News
Arranta Bio Invests in New Manufacturing Facility
Addition of 130,000 sq. ft. Boxborough, MA, manufacturing facility to supply clinical and commercial microbiome products.Tim Wright, Editor, Contract Pharma 03.09.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Celonic to Boost Cell & Gene Therapy Production
Will establish a new facility in the upcoming Life Science Park Rheintal in Stein, Switzerland.Tim Wright, Editor, Contract Pharma 03.05.21
-
Breaking News | Promotions & Moves
PCI Pharma Services Appoints SVP, CFO
Tom De Weerdt brings more than 20 years of experience in financial leadership roles at large, global corporations.Kristin Brooks 03.02.21
-
Breaking News | Collaborations & Alliances | Industry News
Phlow Corp. and USP Form Alliance
Focused on continuous manufacturing to increase supply of essential medicines for U.S. patients.Tim Wright, Editor, Contract Pharma 03.01.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
BMS Expands Cell Therapy Manufacturing Capabilities
New state-of-the-art cell therapy manufacturing facility under construction to expand global footprint.Tim Wright, Editor, Contract Pharma 03.01.21
-
Breaking News | Promotions & Moves
Spark Therapeutics Appoints CTO
Cynthia Pussinen will oversee manufacturing and technical operations, including pipeline process development, preclinical and clinical manufacturing.Kristin Brooks 02.26.21
-
Manufacturing Equipment Trends
Andreas Mattern of Syntegon Technology discusses latest technologies being leveraged in manufacturing equipment today.Kristin Brooks 02.25.21
-
Bio News | Breaking News | Industry News
High Purity New England Bolsters Biopharma Solutions Services
Launches customizable cell culture bioreactor line.Tim Wright, Editor, Contract Pharma 02.25.21
-
Analytical Services | Breaking News | Facilities | Industry News | Laboratory Testing
ACG Launches ACG Laboratories
Opens a process development lab in Shirwal, India.Tim Wright, Editor, Contract Pharma 02.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Catalent Acquires Delphi Genetics
Launches US plasmid manufacturing site to establish global pDNA development and manufacturing capabilities.Tim Wright, Editor, Contract Pharma 02.23.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
MaxiVAX, Minaris Enter Cell Therapy Mfg. Agreement
Minaris will provide GMP manufacturing, freezing and shipping of the MVX-ONCO-2 capsules from its site near Munich, Germany.Kristin Brooks 02.22.21
-
Breaking News | Industry News | Promotions & Moves
CDMO Recro Strengthens Leadership Team
Names CDMO industry thought leader Jim Miller to board and selects Ryan Lake as CFO.Tim Wright, Editor, Contract Pharma 02.12.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Catalent, Trizell Enter Cell Therapy Deal
Sign development and manufacturing agreement with for macrophage-based advanced cell therapy.Tim Wright, Editor, Contract Pharma 02.08.21
-
Breaking News | Industry News | Information Technology
Syntegon Validates First AI-equipped Visual Inspection System
Syringe inspection machine with AI successfully validated in a customer’s production line.Tim Wright, Editor, Contract Pharma 02.02.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lonza Launches Cryopreserved Leukopaks
Customizable cryopreserved Leukopaks aim to provide greater flexibility in immunology and cell therapy research.Kristin Brooks 01.28.21
-
Bio News | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News | Parenterals
Ajinomoto Bio-Pharma, Humanigen Expand Manufacturing Agreement
Ajinomoto will support fill finish for investigational COVID-19 therapeutic, lenzilumab, nearing completion of phase 3 study.Tim Wright, Editor, Contract Pharma 01.27.21
-
Breaking News | Formulation Development | Industry News | Methods Development
Adare Pharma Solutions Opens New Small-Scale Lab
Vandalia, OH lab offers customizable, flexible systems designed to expedite formulation and process development services.Kristin Brooks 01.26.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Bone Therapeutics, Rigenerand Ink Cell Therapy Deal
Enter an agreement for a process development partnership.Contract Pharma Staff 01.19.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
Pays more than $800 million to expand global capacity and address growing demand for cell and gene therapy.Contract Pharma Staff 01.15.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Cytiva Delivers Modular Biologics Factory to Lonza
Site to become a strategic base in China for Lonza to provide CDMO services throughout Asia Pacific region.Contract Pharma Staff 01.14.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center
FUJIFILM Diosynth Biotechnologies will provide GMP contract process development and manufacturing services as part of its role in the new center.Contract Pharma Staff 01.14.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News | Process Development
Capricor, Lonza Enter CAP-1002 Development Agreement
Lonza will perform process development activities for late-clinical and commercial-scale GMP manufacturing of CAP-1002.Contract Pharma Staff 01.12.21
-
Oligonucleotides
Syngene's services encompass Therapeutic oligonucleotides, Diagnostic Oligonucleotides, Enzymatic synthesis and analytical services.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Genezen Laboratories Receives Growth Equity Investment
Will fund the completion of the company’s lentiviral vector production facility.Contract Pharma Staff 01.05.21
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Fujifilm to Invest $40M in New Facility
State-of-the-art viral vector and advanced therapy process development and manufacturing facility will be located in Boston area.Contract Pharma Staff 01.05.21
-
Breaking News | cGMP Manufacture
Ajinomoto Bio-Pharma and Revance Therapeutics Partner
Sign manufacturing agreement for supply of DaxibotulinumtoxinA for injection.Contract Pharma Staff 12.22.20
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Lonza Expands Conjugation Facility in Visp
Two additional manufacturing suites will provide development and manufacturing capacity for preclinical to commercial supply.Contract Pharma Staff 12.21.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Thermo Fisher Expands Plasmid DNA Mfg. Capabilities
New 67,000-square-foot Carlsbad, CA cGMP site will accelerate commercialization of plasmid-based medicines and vaccines.Contract Pharma Staff 12.17.20
-
Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
Passage Bio Invests in Gene Therapy Manufacturing R&D Site
In combination with dedicated cGMP suite at Catalent, the new lab creates foundation for integrated AAV gene therapy manufacturing.Contract Pharma Staff 12.17.20
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News | Process Development | Scale-up/Technology Transfer
CHA Biotech Launches Global CDMO Biz
Matica Biotechnology to construct GMP facility for viral vector production in Texas.Contract Pharma Staff 12.16.20
-
Breaking News | Industry News
CPI Scales Up Manufacturing of Pyocin S5
A promising treatment for lung infection in cystic fibrosis patients developed by the University of Glasgow.Contract Pharma Staff 12.14.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Orgenesis, Cure Therapeutics Form JV
Aims to advance point-of-care development and commercialization of cell and gene therapies.Contract Pharma Staff 12.10.20
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News | Parenterals
Thermo Fisher Scientific Further Expands Global Footprint
Will expand sites in Greenville, NC; Swindon, UK; and Ferentino and Monza, Italy for sterile drug product development and commercial manufacturing.Contract Pharma Staff 12.10.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
atbtherapeutics, iBio CDMO Enter Manufacturing Agreement
Will work together for the industrialization of the GMP manufacturing process of atbtherapeutics’ atbodies.Contract Pharma Staff 12.09.20
-
APIs | Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News
Piramal Invests $32M to Expand Michigan Facility
Includes additional capacity in Potent and Non-Potent API development and manufacturing.Contract Pharma Staff 12.08.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Tubulis, WuXi Biologics and WuXi STA Form Strategic Pact
Will advance a new generation of antibody-drug conjugates towards clinical evaluation.Contract Pharma Staff 12.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
iBio to Provide CDMO Services for ATB Therapeutics
iBio will produce ATB’s bioengineered antibody-toxin fusion proteins.Contract Pharma Staff 12.03.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Formulation Development | Industry News
Lonza Expands Development, Mfg. Capabilities at Bend Site
Investment will add 11 new suites for particle engineering and drug product capacity to improve program lead times.Contract Pharma Staff 11.30.20
-
Breaking News | Industry News | Promotions & Moves
Frontida BioPharma Appoints EVP Technology
Dr. Praful Agrawala brings years of pharmaceutical product development leadership experience to the company.Contract Pharma Staff 11.20.20
-
Breaking News | Facilities | Industry News
CordenPharma Expands Peptide Development Capacity
Increases CoE for peptide development capacity to support European domestic growth.Contract Pharma Staff 11.18.20
-
Bio News | Breaking News | Industry News
Bionova Scientific Secures First Client Commitment
Its new biologics manufacturing facility is still months from completion.Contract Pharma Staff 11.18.20
-
APIs | Breaking News | Industry News
Almac Gets Grant From COVID-19 Therapeutics Accelerator
Will work to enable efficient manufacturing of remdesivir in Response to COVID-19.Contract Pharma Staff 11.18.20
-
Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
Syntegon Opens New OSD Customer Center
Six times more cleanroom capacity for customer projects in Waiblingen, Germany.Contract Pharma Staff 11.18.20
-
Cell & Gene Therapy Supply Chain: Early Preparation is Key
Supply chain management for cell and gene therapies requires precise demand planning and forecasting.Matthew Farabaugh, Chief Financial Officer, The Discovery Labs 11.17.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Vibalogics Establishes U.S. Presence
Will open virotherapy facility in Boston and plans to invest $150 million.Contract Pharma Staff 11.16.20
-
Bioanalytical Services | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
CDMOs: Keeping up with Science & Technology
Enhancing the development of increasingly advanced and complex drug candidates is needed to drive growth in the industry.Kristin Brooks, Contract Pharma 11.12.20
-
Breaking News | Industry News
TCR² Therapeutics, ElevateBio Expand TC-210 Mfg. Capacity
Strategic partnership will leverage technical capabilities at ElevateBio for the production of TC-210 to support Phase II clinical trial.Contract Pharma Staff 11.11.20
-
Breaking News | Collaborations & Alliances | Drug Delivery | Industry News | Parenterals
Ypsomed Collaborates with Schott and Lonza
Aims to deliver a comprehensive solution for wearable patch injectors.Contract Pharma Staff 11.10.20
-
Breaking News | Industry News | Laboratory Testing
Dalton Pharma Services Expands Capabilities
Offers extractables and leachables testing services.Contract Pharma Staff 11.10.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | R&D
Sai Life Sciences to Expand Biology Capabilities
Begins construction of new 75,000 sq. ft. facility in Hyderabad; adding 170 biologists to team.Contract Pharma Staff 10.28.20
-
Breaking News | Industry News | Promotions & Moves
DCAT Elects New President
Sean Diver will serve a one-year term, ending October 31, 2021.Contract Pharma Staff 10.28.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
3P Biopharmaceuticals and SpyBiotech Enter Vaccine Contract Manufacturing Agreement
Looking towards completing production in 2021.Contract Pharma Staff 10.26.20
-
Breaking News | Collaborations & Alliances | Facilities | Industry News
Construction Starts on the Medicines Manufacturing Innovation Center
Will offer next-gen solutions in small molecule and pharmaceutical manufacturing.Contract Pharma Staff 10.26.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News | Process Development
ProBioGen, Heidelberg Pharma Ink ATAC Agreement
ProBioGen is conducting cell line development, process development and GMP manufacturing of the mAb intermediates of Heidelberg’s ATAC molecules for cancer.10.22.20
-
APIs | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
JSR Life Sciences Expands European Footprint
Will co-locate primary European operations for affiliate companies KBI Biopharma and Selexis SA in Geneva’s ZIPLO campus.10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy
Will collaborate for fast-track development of DNP-019, a potential COVID-19 antibody therapy.10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Promotions & Moves
The Discovery Labs Appoints President and COO
Taps former Lonza Exec, Jeorg Ahlgrimm.Contract Pharma Staff 10.15.20
-
APIs
Understanding the Importance of Crystallization Processes
Crystallization is a crucial aspect of a molecule’s development and can be used to avoid unnecessary cost, risk and development delays.Dr. Craig Callahan, Project Scientist, Cambrex Edinburgh 10.14.20
-
Capsules | Solid Dosage/Creams/Ointments
Capsule Technology Trends
A look at the capsule market with a particular focus on the factors driving increased demand in non-gelatin-based formulations.Julien Lamps, Product Manager, Lonza 10.14.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
KindredBio Expands Manufacturing Agreement with Vaxart
Centaur will manufacture Vaxart’s oral vaccine for COVID-19 and other vaccine candidates.Contract Pharma Staff 10.13.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
MilliporeSigma Launches VirusExpress Platform
Scalable platform increases dose yields and reduces process development time for cell and gene therapies.10.13.20
-
Analytical Services | Breaking News | Formulation Development | Industry News | Laboratory Testing
Cambrex Completes Edinburgh Expansion
Doubles the facility's footprint to 15,000 sq.-ft., existing lab space is refurbished, and an additional 3,500 sq.-ft. of lab space added.Contract Pharma Staff 10.12.20
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Facilities | Industry News
Abzena Invests $60M Into cGMP Manufacturing Capacity
New facility in San Diego houses a process development laboratory and two new cGMP manufacturing cleanrooms.Contract Pharma Staff 10.08.20
-
Breaking News | Promotions & Moves
Almac Sciences Appoints VP
Dan Bayston has been with the company since 2003.Contract Pharma Staff 10.08.20
-
Biologics, Proteins, Vaccines | Breaking News
Kindred Bio Expands Agreement with Vaxart
Centaur will manufacture Vaxart’s oral vaccine for COVID-19 and other vaccine candidates.Contract Pharma Staff 10.07.20
-
Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
FDA Approves First Drug Using AJIPHASE Production Process
AJIPHASE platform is for the development and cGMP manufacture of high quality and purity commercial quantities of oligonucleotides and peptides.Contract Pharma Staff 10.07.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
iBio Enters into Agreement with Safi Biosolutions
To develop growth factors and cytokines using the FastPharming system.Contract Pharma Staff 10.06.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Preclinical Outsourcing
Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200
Paves the way towards getting OCU200 in the clinic by first half of 2022.Contract Pharma Staff 10.06.20
-
Breaking News | Collaborations & Alliances | Drug Development
Diamond Pharma Services Supports GenSight Biologics
Provides EU regulatory, pharmacovigilance, quality and compliance support for LUMEVOQ.Contract Pharma Staff 10.05.20
-
Breaking News | Promotions & Moves
3P Expands Management Team
Adds José Luis Bartolomé as operational excellence and continuous improvement director.Contract Pharma Staff 10.02.20
-
APIs | Breaking News | cGMP Manufacture | Industry News
BIAL, Recipharm Expand Long-Term API Supply Pact
Expanded agreement follows approval and launch of Opicapone in Japan to treat Parkinson’s.Contract Pharma Staff 10.01.20
-
Capsules | Solid Dosage/Creams/Ointments
Beyond the Boundaries
New capsule types resolve emerging formulation needs.Sven Stegemann, ACG Capsules 09.09.20
-
Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
Swiss American CDMO Expands in Texas
Adds new 131,760 square-foot industrial facility.Contract Pharma Staff 09.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Mapp Biopharma Partners with CDMO Avid Bioservices
For clinical development of novel human monoclonal antiviral antibody.Contract Pharma Staff 08.26.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
CDMO Ology Bioservices Gets $106.3M U.S. Army Contract
To reserve production capacity in support of Operation Warp Speed.Contract Pharma Staff 08.26.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Maravai LifeSciences Expands CDMO Capabilities at TriLink
To increase small molecule manufacturing capacity for additional scale-up of CleanCap messenger RNA capping technology for vaccine and therapeutic programs.Contract Pharma Staff 08.25.20
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
AGC Biologics Enters CDMO Partnership with Ono Pharmaceuticals
To manufacture biopharmaceuticals at clinical development stage.Contract Pharma Staff 08.20.20
-
Breaking News | Industry News
Swiss American CDMO Appears In 2020 Inc. 5000 List
Named one of the fastest-growing private companies in America.Contract Pharma Staff 08.18.20
-
Breaking News | Facilities | Industry News | R&D
CDMO Sai Life Sciences Opens New Facility
State-of-the-art research and technology center is located in Hyderabad, India and completes first phase in $150 million investment.Contract Pharma Staff 08.18.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Beroni Signs Agreement with CDMO Genscript Biotech
To conduct further study to develop nanobody-based medical solution for COVID-19.Contract Pharma Staff 08.12.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Sekisui Diagnostics Invests in Biopharma CDMO Capacity
Investing £14.4 million in its biopharma CDMO business aimed at cGMP microbial capacity expansion at its site in Maidstone, Kent.Contract Pharma Staff 08.04.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Altimmune and CDMO Vigene Enter COVID-19 Vax Pact
Ink manufacturing agreement for AdCOVID single dose intranasal vaccine candidate.Contract Pharma Staff 08.03.20
-
Breaking News | cGMP Manufacture
Sekisui Invests $18.93 Million in Biopharma CDMO Business
Expands cGMP microbial capacity in Maidstone, Kent site.Contract Pharma Staff 07.31.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
GenScript Expands CDMO Capabilities
Launches CDMO segment "GenScript ProBio" dedicated to providing services from discovery to commercialization.Contract Pharma Staff 07.23.20
-
Breaking News | Industry News
Ajinomoto Bio-Pharma Launches Ajility
A fast track platform for drug product manufacturing.Contract Pharma Staff 06.30.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development
SwiftScale Manufactures COVID-19 Antibody Candidate
Uses rapid biologics manufacturing technology to accelerate development of treatments.Contract Pharma Staff 06.09.20
-
Drug Delivery
Not Your Father’s Oral Thin Film
A look at how oral film drug delivery is evolving.Rodolphe Obeid, Vice President of Operations, IntelGenx 06.04.20
-
A Guide to Vaccine Development from Lubrizol Life Science
The current COVID-19 pandemic emphasizes the need for safe and effective vaccines against new pathogens.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
WuXi Launches CAR-T Cell Therapy Platform
Will enable biotechnology companies and researchers to accelerate the development, manufacturing and release of cell and gene therapies for patientsContract Pharma Staff 05.18.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Vibalogics to Manufacture Clinical Material for Janssen
CDMO to provide additional clinical trial material for COVID-19 vaccine candidateContract Pharma Staff 05.14.20
-
APIs | Breaking News | cGMP Manufacture | Excipients | Industry News
Evonik Commissions Advanced Biomaterials Production Facility
Expands range of CMO services for the scale-up and commercial manufacturing of customer’s own excipients in Birmingham, AL.Contract Pharma Staff 05.13.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
HJB, Mabspace Ink Development and Manufacturing Agreement
Program aims to bring more efficacious treatment options to cancer patientsContract Pharma Staff 05.12.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Themis Collaborates with ABL Europe
ABL will manufacture Themis’ SARS-CoV-2 vaccine candidate in FranceContract Pharma Staff 05.12.20
-
-
Breaking News | Collaborations & Alliances | Industry News
Sterling Begins HCQ Production in UK
Partners with Accord Healthcare for the manufacture of potential COVID-19 treatmentContract Pharma Staff 05.11.20
-
Breaking News | Industry News | Promotions & Moves
Alcami Makes Senior Leadership Appointments
Sally Langa to lead biz dev efforts; Kimberly McClintock returns to head-up marketingContract Pharma Staff 05.08.20
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News
Aji Bio-Pharma, CytoDyn Enter COVID-19 Mfg. Pact
Aji Bio-Pharma provides drug product aseptic fill finish services for CytoDyn's Leronlimab, currently being used in clinical trials for COVID-19 patientsContract Pharma Staff 05.05.20
-
Bio News | Biologics, Proteins, Vaccines | Drug Development | Drug Discovery
Trio Pharma, Aji Bio-Pharma Enter ADC Alliance
To evaluate AJICAP, Aji Bio's site-specific conjugation technology for the development of TRIObody Drug ConjugatesContract Pharma Staff 04.30.20
-
Breaking News | Drug Development | Industry News
AGC Biologics, AdaptVac Partner to Develop COVID-19 Vaccine
Will leverage AdaptVac's Virus-Like Particle (VLP) technology that could provide a solution to protect against new SARS-CoV-2 infections.Contract Pharma Staff 04.27.20
-
-
Analytical Services | Bioanalytical Services | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Formulation Development
Contract Pharma’s 20th Anniversary Series: Ajinomoto Bio-Pharma
David Enloe of Ajinomoto Bio-Pharma Services shares his perspective on market changes over the years and the evolution of more integrated outsourcingKristin Brooks, Contract Pharma 11.11.19
-
Analytical Services | Industry News | QA/QC
Recipharm Launches Recipharm Analytical Solutions
Stand-alone service offers analytical services including method development, method validation, and stability program design and implementation11.04.19
-
-
Breaking News | cGMP Manufacture | Industry News
ANI Launches New CDMO Brand ANI Global Source
Following the integration of WellSpring, the specialty CDMO will support late stage development and commercial manufacture of pharmaceutical products.10.29.19
-
-
Bio News | Bioassay Development | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Eurofins Discovery and Escient Form Collaboration
Eurofins to provide assay development and drug discovery services.10.28.19
-
Contract Pharma’s 20th Anniversary Retrospective
A look back a the pharma/biopharma industry and the future of outsourcing.Kristin Brooks, Managing Editor, Contract Pharma 10.15.19
-
APIs | cGMP Manufacture | Industry News
Aji Bio-Pharma Buys Out India Joint Venture
JV, formed in 2011, provides small molecule intermediates and API manufacturing to the pharmaceutical industry08.29.19
-
Bio News | Breaking News | Industry News | Promotions & Moves
Avid Names Richard Hancock Interim President & CEO
Industry veteran with over 30 years of operational and executive experience succeeds Roger Lias05.20.19
-
APIs | Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
GeneDesign Joins Ajinomoto Bio-Pharma Services
Opens oligonucleotide API development center04.09.19
-
Bio News | Breaking News | Promotions & Moves
Ajinomoto Appoints VP of Sales & Marketing
Jean-Baptiste Agnus joins Ajinomoto Bio-Pharma Services from Novasep04.03.19
-
APIs | Breaking News | cGMP Manufacture | Fill/Finish | Industry News
Ajinomoto Bio-Pharma Services Expands
Invests more than $100 million to further expand offerings and capabilities in both the U.S. and Belgium03.12.19
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Ajinomoto, XL-protein Forge Strategic Alliance
Ajinomoto will apply its Corynex expression system with XL-protein's PASylation technology to develop a series of therapeutic compounds12.18.18
-
Bio News | Drug Development | Drug Discovery | Industry News | R&D | Reader Showcase
Aji Bio-Pharma Introduces New ADC Mfg. Technology
AJICAP technology lets developers of ADCs to better control the location of payload conjugation to an antibody11.28.18
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances
Ajinomoto Bio-Pharma Services, Precision Nanosystems in Mfg. Pact
Will leverage PNI's NanoAssemblr to support clients into clinical development through to commercialization of nanomedicines10.23.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Ajinomoto Althea and OmniChem Integrate
Businesses and operations will integrate as a unified CDMO, and will operate as Ajinomoto Bio-Pharma Services10.02.18
-
cGMP Manufacture | Industry News | Promotions & Moves
Ajinomoto Althea Makes Key VP Hires
Bert Barbosa to serve as VP of Drug Product Manufacturing and Darwin Richardson to serve as VP of Compliance05.31.18
-
Industry News
Ajinomoto Althea CEO Recognized for Achievements
Recognized for leading significant growth and fostering several technical and organizational development initiatives07.06.17
-
APIs | Breaking News | Industry News
Ajinomoto OmniChem Launches Flow Chemistry for API Commercial Mfg.
Building out this continuous flow platform is supported by the multi-year grant awards from the Belgian government04.13.17
-
Aseptic Processing | Breaking News | Fill/Finish | Parenterals | Promotions & Moves | Regulatory Affairs
Ajinomoto Althea Bolsters Regulatory Affairs Team
Names Lori McDonald vice president of compliance04.06.17
-
Clinical Trial Materials | Drug Development | Industry News | Scale-up/Technology Transfer
Biologic Candidate Using Ajinomoto CORYNEX System Enters Trials
Althea successfully scales up and produces GMP material for Phase I trial using CORYNEX system10.04.16
-
APIs | Inspections
The Western API Industry
Temporary reprieve or lasting recovery?Dr. Enrico T. Polastro, Arthur D. Little 01.28.16
-
Collaborations & Alliances
Filament BioSolutions, Ajinomoto Form Partnership
Focus will be on developing a portfolio of evidence-based medical foods01.11.16
-
Breaking News | Industry News
-
Breaking News | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Process Development
